Authors:
Baumann, M
Bischoff, H
Schmidt, D
Griesinger, C
Citation: M. Baumann et al., Combinatorial synthesis of cholesterol ester transfer protein-mRNA ligandsand screening by nondenaturating gel-electrophoresis, J MED CHEM, 44(13), 2001, pp. 2172-2177
Authors:
Qian, MX
Nahoum, V
Bonicel, J
Bischoff, H
Henrissat, B
Payan, F
Citation: Mx. Qian et al., Enzyme-catalyzed condensation reaction in a mammalian alpha-amylase. High-resolution structural analysis of an enzyme-inhibitor complex, BIOCHEM, 40(25), 2001, pp. 7700-7709
Authors:
Nahoum, V
Roux, G
Anton, V
Rouge, P
Puigserver, A
Bischoff, H
Henrissat, B
Payan, F
Citation: V. Nahoum et al., Crystal structures of human pancreatic alpha-amylase in complex with carbohydrate and proteinaceous inhibitors, BIOCHEM J, 346, 2000, pp. 201-208
Authors:
Oikonomakos, NG
Tsitsanou, KE
Zographos, SE
Skamnaki, VT
Goldmann, S
Bischoff, H
Citation: Ng. Oikonomakos et al., Allosteric inhibition of glycogen phosphorylase a by the potential antidiabetic drug 3-isopropyl 4-(2-chlorophenyl)-1,4-dihydro-1-ethyl-2-methyl-pyridine-3,5,6-tricarboxylate, PROTEIN SCI, 8(10), 1999, pp. 1930-1945
Authors:
Bischoff, H
Stahelin, HB
Vogt, P
Friderich, P
Vonthein, R
Tyndall, A
Theiler, R
Citation: H. Bischoff et al., Immobility as a major cause of bone remodeling in residents of a long-staygeriatric ward, CALCIF TIS, 64(6), 1999, pp. 485-489
Authors:
Diehl, V
Franklin, J
Hasenclever, D
Tesch, H
Pfreundschuh, M
Lathan, B
Paulus, U
Sieber, M
Ruffer, JU
Sextro, M
Engert, A
Wolf, J
Hermann, R
Holmer, L
Stappert-Jahn, U
Winnerlein-Trump, E
Wulf, G
Krause, S
Glunz, A
von Kalle, K
Bischoff, H
Haedicke, C
Duhmke, E
Georgii, A
Loeffler, M
Citation: V. Diehl et al., BEACOPP: A new regimen for advanced Hodgkin's disease, ANN ONCOL, 9, 1998, pp. 67-71
Authors:
Diehl, V
Franklin, J
Hasenclever, D
Tesch, H
Pfreundschuh, M
Lathan, B
Paulus, U
Sieber, M
Rueffer, JU
Sextro, M
Engert, A
Wolf, J
Hermann, R
Holmer, L
Stappert-Jahn, U
Winnerlein-Trump, E
Wulf, G
Krause, S
Glunz, A
von Kalle, K
Bischoff, H
Haedicke, C
Duehmke, E
Georgii, A
Loeffler, M
Citation: V. Diehl et al., BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: Interim report from a trial of the German Hodgkin's Lymphoma Study Group, J CL ONCOL, 16(12), 1998, pp. 3810-3821